XML 42 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Common Stock
Class A Common Stock
Additional Paid-In Capital
Accumulated other comprehensive loss
Accumulated Deficit
Total
Beginning Balance (in shares) at Dec. 31, 2020       4,950,129        
Beginning Balance at Dec. 31, 2020       $ 4,950 $ 3,251,240   $ (25,737,640) $ (22,481,450)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options       $ 118 354,316     354,434
Issuance of common stock upon exercise of stock options (in shares)       117,846        
Issuance of common stock upon exercise of warrants       $ 308 926,817     927,125
Issuance of common stock upon exercise of warrants (in shares)       308,308        
Conversion of Preferred Stock into common stock $ (21,119,940) $ (61,772,761) $ (82,892,701) $ 11,939 82,880,762     82,892,701
Conversion of Preferred Stock into common stock (in shares) (2,495,933) (6,032,145)   11,939,281        
Issuance of common stock upon initial public offering, net of issuance costs       $ 8,625 118,185,808     118,194,433
Issuance of common stock upon initial public offering, net of issuance costs (in shares)       8,625,000        
Issuance of common stock for acquisition       $ 380 7,874,620     7,875,000
Issuance of common stock for acquisition, shares       379,635        
Stock-based compensation expense         1,802,623     1,802,623
Net loss             (33,535,748) (33,535,748)
Other comprehensive loss           $ (49,009)   (49,009)
Ending Balance at Dec. 31, 2021       $ 26,320 215,276,186 (49,009) (59,273,388) 155,980,109
Ending Balance (in shares) at Dec. 31, 2021       26,320,199        
Beginning Balance at Dec. 31, 2020 $ 21,119,940 $ 36,983,910 58,103,850          
Beginning Balance (in shares) at Dec. 31, 2020 2,495,933 3,619,292            
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of convertible preferred stock, net of issuance costs   $ 24,788,851 $ 24,788,851          
Issuance of convertible preferred stock, net of issuance costs (in shares)   2,412,853            
Issuance of common stock upon exercise of stock options       $ 99 300,280     $ 300,379
Issuance of common stock upon exercise of stock options (in shares)       98,533       98,533
Stock-based compensation expense         4,064,446     $ 4,064,446
Net loss             (50,513,568) (50,513,568)
Other comprehensive loss           18,889   18,889
Ending Balance at Dec. 31, 2022       $ 26,419 $ 219,640,912 $ (30,120) $ (109,786,956) $ 109,850,255
Ending Balance (in shares) at Dec. 31, 2022       26,418,732